Relief Therapeutics Holding AG (RLFTF)

[Andy2018]

I see plasma is not a competitor as RLFTF only having EXPANDED ACCESS approval which is treating sickest of the sick. DMC will HALT the critical patient trial and recommend FDA accelerated approval. Many HUGE catalysts are pending.

Understand the inclusion criteria aviptadil trail had ventilator patients, ECMO patients. They are the sickest patients so critical patients only have one option Aviptadil expanded access once they exhaust treatment options.